Fenugreek and heart

What 2 graded rows on fenugreek agree on for heart, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Fenugreek page, with its PubMed record.

Your question

Supplement
Fenugreek Choose another

Fenugreek and heart

2 rows · 933 people

Split. 1 row found an improvement and 1 had mixed results.

Mixed
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.
  • Grade C× 2
Rows
2
Trials
2
At least: a review without a trial count
People
933
Pooled reviews may count some twice

What the rows share

From the rows

The best-graded row, grade C, is a meta-analysis of 560 people (2020) and found an improvement.

The rows run from 373 to 560 people, published from 2020 to 2023: 2 pooled reviews and 0 single studies.

The rows

1 improved · 1 mixed
  1. Grade CBlood lipids (total and LDL cholesterol, triglycerides, HDL) · Improved

    Meta-analysis · n 560 · 2020 · Adults in 12 RCTs (14 arms)

    Not stated in the abstract · Not stated in the abstract

    Total cholesterol fell by about 9.4 mg/dL, triglycerides by 13.8 mg/dL and LDL by 6.6 mg/dL, and HDL rose by 3.5 mg/dL versus control. Body weight and BMI did not change.

    Row on the Fenugreek page · PubMed 32087319 (opens PubMed)

  2. Grade CBlood pressure · Mixed

    Meta-analysis · n 373 · 2023 · Participants in 6 RCTs

    Varied; 15 g/day or more in the subgroup with significant effects · 12 weeks or less in the subgroup with significant effects

    Systolic pressure fell by about 3.46 mmHg; diastolic pressure did not change significantly overall. Both fell in the subgroup given 15 g/day or more for 12 weeks or less.

    Row on the Fenugreek page · PubMed 36763260 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.